Skip to content
2000
Volume 2, Issue 2
  • ISSN: 1874-4710
  • E-ISSN: 1874-4729

Abstract

New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.

Loading

Article metrics loading...

/content/journals/crp/10.2174/1874471010902020092
2009-04-01
2025-09-18
Loading full text...

Full text loading...

/content/journals/crp/10.2174/1874471010902020092
Loading

  • Article Type:
    Research Article
Keyword(s): Copper radiosiotopes; diagnosis; PET; radiopharmaceuticals; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test